Learn More
Medchemexpress LLC N-((1R,3S)-3-(4-acetylpiperazin-1-yl)cyclohexyl)-7-fluoro-4-methyl-1H-indole-2-carboxamide | 2411748-50-8 | 99.1% | C22H29FN4O2 | 10MG

Supplier: Medchemexpress LLC HY14485810MG
EZM0414 is a selective, orally bioavailable small-molecule inhibitor of the histone methyltransferase SETD2, developed for preclinical research applications. It exhibits potent biochemical and cellular activity and is intended for laboratory research into SETD2-driven biology and oncology models.
- Selective SETD2 inhibitor with biochemical IC50 ~18 nM.
- Demonstrates cellular activity (IC50 ~34 nM).
- Orally bioavailable in preclinical models.
- High purity (≈99%) suitable for biochemical and cellular assays.
- Applicable to research on hematologic and solid tumor models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.